Ignite Creation Date:
2025-12-24 @ 10:13 PM
Ignite Modification Date:
2025-12-29 @ 2:35 PM
Study NCT ID:
NCT02027935
Status:
COMPLETED
Last Update Posted:
2024-10-08
First Post:
2014-01-02
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
CD8+ Antigen-Specific T Cells, Cyclophosphamide, Aldesleukin, and Ipilimumab in Treating Patients With Metastatic Melanoma
Sponsor:
M.D. Anderson Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-01-22
Start Date Type:
ACTUAL
Primary Completion Date:
2024-04-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-04-12
Completion Date Type:
ACTUAL
First Submit Date:
2014-01-02
First Submit QC Date:
None
Study First Post Date:
2014-01-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2024-06-04
Results First Submit QC Date:
None
Results First Post Date:
2024-10-08
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-18
Last Update Post Date:
2024-10-08
Last Update Post Date Type:
ACTUAL